Journal

figure

Erratum: Relationship between khat chewing and upper digestive tract cancers among male patients in Hargeisa: a preliminary case-control study

18 March 2026
ASTRO 2012: Many incurable lung cancer patients misunderstand the goals  and limitations of palliative radiation therapy - 3520.png

Pharmacogenetic landscape of epidermal growth factor receptor mutations in Kurdish non-small cell lung cancer patients: implications for precision oncology

12 March 2026
benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

Coping and family functionality in women with diabetes and breast cancer

12 March 2026
Integration of palliative care in oncology – the intersection of cultures

Spirituality, symptom burden and palliative care needs assessed by the Palliative Outcome Scale in those with cancer: a cross-sectional study

12 March 2026
figure

Profiling of tumour board characteristics and functioning for cancer care under hospitals registered under National Cancer Registry Programme in India

12 March 2026
Image

Brachytherapy reirradiation for local recurrences of gynaecological cancers: two clinical cases, literature review and OAR constraints

12 March 2026
 Triple-negative breast cancer subtypes identified using microRNA  - 3789.jpg

Clinical, therapeutic and prognostic characteristics of de novo metastatic breast cancer in Cameroon

12 March 2026
figure

Cancer profile among medical evacuees from São Tomé and Príncipe: a descriptive study (2019–2025)

12 March 2026
gastric cancer

Gastric cancer, what’s new from International Gastric Cancer Congress (IGCC) in Amsterdam: a scientific report from Salerno 2025 conference

9 March 2026
access, affordability and disruptions to cancer care in India

Patient and public involvement in cancer care and research: the Indian perspective

9 March 2026
figure

Symptom palliation with QUADSHOT regimen for advanced cervical cancer patients in Tikur Anbessa Specialised Hospital: a prospective cohort study

9 March 2026
ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer - 3431.png

Pattern of resistance on first-line EGFR-directed therapy in EGFR-positive metastatic NSCLC

9 March 2026
Back to Top